We are international
Donate
TEXT SIZE   


Myeloma Minute
August 11, 2016
08.11.16
August 11, 2016
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: A patient has been in long-term remission after an ASCT, and his light chain level is slowly increasing. Should he be treated?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

August 19-20, 2016
Patient & Family Seminar

Los Angeles, California

August 21, 2016
Community Picnic Day

Los Angeles - Griffith Park

September 10, 2016
Regional Community Workshop

Overland Park, KS

September 17, 2016
Regional Community Workshop

Sacramento, CA

 

 

 

 

 

    

x

Health Canada Approves Ninlaro (ixazomib) for Use in Relapsed/Refractory Multiple Myeloma

Health Canada approved Ninlaro® (ixazomib) capsules for use in combination with lenalidomide and dexamethasone. The Canadian health ministry made the approval for treatment of patients with multiple myeloma who have had at least one prior therapy. Approximately 7,500 Canadians are living with multiple myeloma. This approval was mainly based on the results of the phase 3 TOURMALINE-MM1 trial, which demonstrated that this combination therapy can significantly extend progression-free survival in patients with relapsed/refractory MM. To learn more about this recent approval in Canada, click HERE.

 

x

Summer Edition of Myeloma Today: Tackling the Rising Cost of Myeloma Health Care...and More

 

The latest issue of Myeloma Today is out with news from the annual International Myeloma Working Group Summit, which took place in Copenhagen in June 2016. Leading myeloma experts gathered to tackle the rising cost of myeloma care by identifying myeloma treatment guidelines that not only consider cost, but also protect patients from regulations that may limit or distort access. Other important research topics discussed were screening for MGUS, the role of MRD detection, the optimal imaging methods, and the best uses for immune therapies, to name a few. Also included in this issue are highlights from ASCO 2016, the Oncology Nursing Society’s 2016 Satellite Symposium, and reports from patient-centered fundraising events. To download this issue of Myeloma Today, click HERE.

 

 

x

Attend the IMF's Patient & Family Seminar in Los Angeles to Get the Most Up-to-Date Information about Myeloma


 

The IMF will conduct its signature Patient & Family Seminar at the Sheraton Universal Hotel in Los Angeles (Universal City) on August 19–20, 2016. Seminar attendees will hear the most up-to-date information on all aspects of treating myeloma, including how best to manage side effects; best therapies for all disease stages; the latest information for patients opting for transplant; and how best to manage bone disease. Dr. Brian Durie will provide an update on the IMF’s Black Swan Research Initiative®, and information about clinical trials and new drug therapies. Attendees will receive one-on-one access to myeloma experts Drs. Brian Durie, Craig Cole, Rafat Abonour, Robert Vescio, and Philip McCarthy. To register for this seminar, click HERE.

x

Comedian Jim Jefferies and Brad Williams Headline IMF Fundraisers in Hollywood


 

On Tuesday, August 23, 2016, at 8 pm, the Hollywood Improv in Los Angeles will host an IMF Fundraiser. Comedian Forrest Shaw is the evening’s featured act. Forrest organized the benefit in honor of his mother, who is battling myeloma. He made his television debut on “Conan” in 2014 and has performed at some of the nation’s top comedy festivals. Headlining comics for the evening are globetrotter Jim Jefferies and California native Brad Williams. Tickets for the event are only $20 and can be purchased HERE.

 

x

IMF's Community Picnic Day   Fabulous and Free to All




  

Take a break from the PokémonGo craze and come to the IMF’s inaugural Community Picnic Day! Thanks to event sponsor Amgen, anyone can attend this fun-filled event on Sunday, August 21st, in Los Angeles’s beautiful Griffith Park, for FREE! Open to all ages, the IMF Community Picnic Day will provide entertainment for the whole family. Scheduled activities include yoga sessions, Tai Chi instruction, a healthy cooking demonstration, art therapy, and a 1K fun run for kids. Don’t miss out! Click HERE to join us – we look forward to closing out the summer with you!

 

   
 


Join Our Mailing List

 
                                                                We Would Like to Thank Our Sponsors:
 
Takeda Oncology, Celgene, Amgen, and Bristol-Myers Squibb
 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles